» » »

Gene 'Signature' and Lung Cancer Boston MA

In a finding that could lead to a simple blood test to screen for lung cancer, U.S. researchers have identified immune system markers that indicate early-stage lung tumors in people at high risk for lung cancer.

Therese M Mulvey, MD
(617) 479-3550
10 Willard St
Quincy, MA
Business
Commonwealth Physicians Services Inc
Specialties
Oncology

Data Provided by:
Zareh Nazareth DeMirjian
(617) 726-3759
15 Parkman St
Boston, MA
Specialty
Internal Medicine, Hematology / Oncology

Data Provided by:
Evan P Pisick, MD
(617) 636-5582
750 Washington St # 245
Boston, MA
Specialties
Oncology (Cancer)
Gender
Male
Education
Graduation Year: 2007

Data Provided by:
Theodore Sunki Hong
(617) 724-4504
100 Blossom St
Boston, MA
Specialty
Radiation Oncology

Data Provided by:
Ronald Wayne Takvorian, MD
55 Fruit St
Boston, MA
Specialties
Oncology (Cancer)
Gender
Male
Education
Medical School: Stanford Univ Sch Of Med, Stanford Ca 94305
Graduation Year: 1974

Data Provided by:
Barbara Lynn Smith
(617) 724-4800
55 Fruit St
Boston, MA
Specialty
General Surgery, Surgical Oncology

Data Provided by:
Arlan Frank Fuller Jr, MD
(617) 724-4800
55 Fruit St
Boston, MA
Specialties
Oncology (Cancer), Gynecological Oncology
Gender
Male
Education
Medical School: Harvard Med Sch, Boston Ma 02115
Graduation Year: 1971
Hospital
Hospital: Massachusetts Gen Hosp, Boston, Ma
Group Practice: Gillette Center For Women

Data Provided by:
Don C Star, MR
(617) 424-7963
625 Tremont St
Boston, MA
Specialties
Oncology (Cancer)
Gender
Male
Education
Graduation Year: 2007

Data Provided by:
Gregory Alan Abel
(617) 726-2241
55 Fruit St Yaw 7
Boston, MA
Specialty
Internal Medicine, Hematology / Oncology

Data Provided by:
Hedy P Smith
(617) 636-7742
750 Washington St
Boston, MA
Specialty
Hematology / Oncology

Data Provided by:
Data Provided by:

Gene 'Signature' and Lung Cancer

Provided By:

TUESDAY, Dec. 1 (HealthDay News) -- In a finding that could lead to a simple blood test to screen for lung cancer, U.S. researchers have identified immune system markers that indicate early-stage lung tumors in people at high risk for lung cancer.

The researchers examined gene expression profiles in blood samples from 137 people with non-small cell lung cancer and a control group of 91 people with non-malignant lung diseases, such as chronic obstructive pulmonary disease, emphysema or benign lung nodules.

They identified a 29-gene "signature" that was 86 percent accurate in identifying those with lung cancer, who had certain genetic changes in immune cells that the others did not.

Blood samples were taken from 18 of those with lung cancer before surgery to remove their tumors and two to five months after surgery. After surgery, 13 of them showed a decrease or disappearance of the tumor gene signature.

The study was published online Dec. 1 in Cancer Research.

The researchers said it might be possible to use the findings to develop a simple blood test to screen for lung cancer.

"People routinely get blood taken at their doctors' offices for cholesterol levels, diabetes and other standard tests, so why not utilize this method to screen for other conditions such as the risk of developing lung cancer?" Louise C. Showe, a professor in the molecular and cellular oncology and immunology programs and director of the genomics facility at the Wistar Institute in Philadelphia, said in a news release from the institute.

"Such a test could be especially useful for remote areas where, typically, technologies that are used in urban centers are not available," she said. "In addition, this test could be useful in a clinical setting to help to decide whether a small tumor detected on an X-ray is likely to be malignant."

More information

The U.S. National Cancer Institute has more about lung cancer screening.

SOURCE: Wistar Institute, news release, Dec. 1, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com